如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: LL-37 peptide
產(chǎn)品型號(hào): SP-LL37-1
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
LL-37 peptide
SP-LL37-1
LL-37 peptide
的詳細(xì)介紹
LL-37 peptide
|
Name
|
LL-37
|
|
Sequence
|
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
|
|
3-letter-code
|
Leu - Leu - Gly - Asp - Phe - Phe - Arg - Lys - Ser - Lys - Glu - Lys - Ile - Gly - Lys - Glu - Phe - Lys - Arg - Ile - Val - Gln - Arg - Ile - Lys - Asp - Phe - Leu - Arg - Asn - Leu - Val - Pro - Arg - Thr - Glu - Ser
|
|
Notes
|
>95% purity. Also available as LL-37 : Ultra-pure at >98% purity.
|
|
Molecular weight
|
4493.33
|
|
Counter ion
|
TFA
|
|
Solubilization
|
Soluble in pure water.
|
|
Description
|
The cathelicidin anti-microbial peptide LL-37 corresponds to aa 134-170 of the human cationic antimicrobial protein 18 (hCAP18).
|
|
References
|
M. Chromek, Z. Slamov?, P. Bergman, L. Kov?cs, L. Podrack?, I. Ehr?n, T. H?kfelt, G.H. Gudmundsson, R.L. Gallo, B. Agerberth & A. Brauner. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nature Medicine 2006 12:636-641
L. Bandholtz, G. Jacobsson Ekman, M. Vilhelmsson, E. Buentke, B. Agerberth, A. Scheynius, G. H. Gudmundsson. 2006. Antimicrobial Peptide LL-37 Internalized by Immature Human Dendritic Cells Alters their Phenotype. Scandinavian Journal of Immunology 63 (6), 410?419.
|
|
|
|
|
|
|
|
|
|
Order LL-37 peptide
|
Amount
|
Cat.No.
|
|
|
|
|
Unit price
|
|
|
1 mg
|
SP-LL37-1
|
|
|
420 USD
|
BUY
|
|
1 mg x 2
|
SP-LL37-1x2
|
|
|
600 USD
|
BUY
|
|
5 mg
|
SP-LL37-5
|
|
|
1130 USD
|
BUY
|
|
|
|
For larger amounts please inquire.
|
|
Labeled and modified LL-37
|
Name
|
|
|
|
|
|
|
|
|
LL-37 5-FAM
|
5-Carboxyfluorescein on N-terminus.
|
|
LL-37 5-TAMRA
|
5-Carboxytetramethylrhodamine on N-terminus.
|
|
LL-37 biotin
|
Biotin via a 6-carbon spacer (Ahx) on N-terminus.
|
|
LL-37 Lys 5-TAMRA
|
LL-37 with 5-TAMRA labeled Lysine at C-terminus. Amide on C-terminus.
|
|
LL-37 reverse
|
Reverse sequence of LL-37.
|
|
LL-37 scrambled
|
Scrambled version of LL-37.
|
LL-37 antibody
|
Information
|
|
LL-37 antibody product description
|
LL-37 affinity columns
|
Affinity columns are custom made depending on your requirements. Please inquire for more information.
|
|
Information
|
|
Inquire for LL-37 peptide affinity column
|
|
Inquire for LL-37 antibody affinity column
|
Related peptides
|
Name
|
|
Sequence
|
|
|
|
|
|
|
Cys-LL-37
|
CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
|
|
Cys-LL-37-Cys
|
CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC
|
|
LL-37 (acetate)
|
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
|
|
LL-37 : Ultra-pure
|
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
|
|
LL-37 Citrulline
|
LLGDFF(Cit )KSKEKIGKE FK(Cit)IVQ (Cit)IKDFL (Cit)NLVP( Cit)TES
|
|
LL-37 FK-13
|
FKRIVQRIKDFLR
|
|
LL-37 FKR
|
FKRIVQRIKDFLRNLVPRTES
|
|
LL-37 GKE
|
GKEFKRIVQRIKDFLRNLVPR
|
|
LL-37 KRI
|
KRIVQRIKDFLRNLVPRTES
|
|
LL-37 LLG
|
LLGDFFRKSKEKIGKEFKRIV
|
|
LL-37 RKS
|
RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
|
|
LL-37 SKE
|
SKEKIGKEFKRIVQRIKDFLR
|
|
LL-37-Cys
|
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC
|
